The Trump administration confirms it will not approve state requests to impose lifetime limits on Medicaid benefits; a significant number of young adults are providing long-term care for older loved ones and are more likely to be stressed by the caregiving than older counterparts; 5 more states file lawsuit against Purdue Pharma for its alleged role in the opioid epidemic, and Florida files lawsuit against multiple painkiller makers and drug distributors.
While the Trump administration is allowing states more flexibility with their Medicaid coverage, it will not approve lifetime limits. Speaking during an event hosted by The Washington Post, CMS Administrator Seema Verma said that the administration has made it clear to states that it will not approve such limits to Medicaid benefits, reported The Hill. The administration has already rejected Kansas’ request to cap how long people can receive Medicaid benefits, but Maine, Arizona, Utah, and Wisconsin have also requested the ability to impose a lifetime limit. The proposals exempt children, pregnant women, and people with disabilities from coverage limits.
A significant number of young adults are providing long-term care for older loved ones, and they’re more likely to feel stressed by that caregiving than older counterparts who put in longer hours. The Associated Press-NORC Center for Public Affairs Research poll found 17% of young adults are currently providing long-term care, another 19% have provided such care in the past, and another third expect they’ll have to provide long-term care in the next 5 years.
Florida, Texas, Nevada, North Carolina, North Dakota, and Tennessee have joined more than a dozen other states and hundreds of counties that have filed lawsuits against opioid makers for their alleged role in fueling the opioid epidemic. According to The Wall Street Journal, Florida filed suit against painkiller makers, as well as drug distributors. Nevada, North Carolina, North Dakota, Tennessee, and Texas have all filed suit against Purdue Pharma only. Texas and Florida are the most populous states yet to pursue litigation.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More